Search results for "Venous thromboembolism"
Some newer progestogens double thromboembolism risk
Women taking oral contraceptives containing drospirenone or desogestrel had twice the risk of venous thromboembolism as women taking levonorgestrel pills, a new Danish study found.
https://immattersacp.org/weekly/archives/2011/11/01/5.htm
1 Nov 2011
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a new trial, tocilizumab had mixed results, and remdesivir got full approval, among other COVID-19 news.
https://immattersacp.org/weekly/archives/2020/10/27/1.htm
27 Oct 2020
Infection, other factors may increase risk for VTE hospitalization
Infection, treatment with erythropoiesis-stimulating agents, and blood transfusion may increase risk for hospitalization due to venous thromboembolism (VTE), according to a new study.
https://immattersacp.org/weekly/archives/2012/04/10/2.htm
10 Apr 2012
MKSAP Quiz: Evaluation for contraceptive advice
A 37-year-old woman is evaluated for contraceptive advice. She is married and has a 1-year-old child. The patient describes the conception of this child as an “accident” because she often missed taking her previous oral contraceptive. Her menstrual periods have resumed and are regular but heavy. What is the most appropriate female contraceptive option for this patient?
https://immattersacp.org/weekly/archives/2020/02/04/3.htm
4 Feb 2020
Oral anticoagulants and antiplatelets compared for risk of recurrent VTE, major bleeds
All oral anticoagulants and antiplatelet agents reduced recurrence of venous thromboembolism (VTE) compared with placebo, with aspirin reducing risk the least and vitamin K antagonists reducing it the most, a meta-analysis found.
https://immattersacp.org/weekly/archives/2013/09/10/5.htm
10 Sep 2013
Aspirin appears to reduce recurrence of VTE after stopping anticoagulants
Aspirin reduced the risk of venous thromboembolism (VTE) recurrence with no apparent increase in major bleeding in patients who had an initial unprovoked VTE and had discontinued anticoagulant treatment, a study found.
https://immattersacp.org/weekly/archives/2012/06/05/6.htm
5 Jun 2012
IDSA issues new clinical practice guideline for outpatient parenteral antimicrobial therapy
The new guideline updates 2004 recommendations from the Infectious Diseases Society of America (IDSA) with evidence from recent research, particularly on the safety of outpatient parenteral therapy.
https://immattersacp.org/weekly/archives/2018/11/20/5.htm
20 Nov 2018
Low-molecular-weight heparin may not prevent VTE after knee arthroscopy or lower-leg casting, studies find
The Prevention of Thrombosis after Knee Arthroscopy (POT-KAST) and the Prevention of Thrombosis after Lower Leg Plaster Cast (POT-CAST) trials used the same methods and design to compare a prophylactic dose of low-molecular-weight heparin or no anticoagulant therapy.
https://immattersacp.org/weekly/archives/2016/12/13/4.htm
13 Dec 2016
Thoracic society releases guidelines on pulmonary hypertension in sickle cell patients
The American Thoracic Society recently released clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for death from pulmonary hypertension.
https://immattersacp.org/weekly/archives/2014/03/18/4.htm
18 Mar 2014
Aspirin didn't reduce recurrent VTE but did reduce major vascular events
Low-dose aspirin may have therapeutic benefit for patients who have completed initial anticoagulant therapy for an unprovoked venous thromboembolism (VTE) even though the rate of recurrent VTE was not significantly reduced in a recent study.
https://immattersacp.org/weekly/archives/2012/11/13/1.htm
13 Nov 2012